Cellular Assay Kit
NFK Green™ Assay Technology
Indoleamine 2,3-dioxygenase 1 (IDO1) and tryptophan 2,3-dioxygenase (TDO) are enzymes that convert L-tryptophan into NFK, which is the first step in the kynurenine pathway of tryptophan degradation. IDO1 and TDO are important drug target for cancer immunotherapy and neurodegenerative diseases. NFK can form a complex with the chemical probe NFK Green™ and can thereby be detected in a fluorescence assay. The cellular assay kit can be used to determine the potency of IDO1 and TDO inhibitors in cells that express (one of) these enzymes, such as MDA-MB-231 or A375 cells for IDO1 and A-172 or SW48 cells for TDO.
Kits contents
Component | Description | Stock conc. in kit | Conc. in assay |
---|---|---|---|
Substrate | L-Tryptophan | Dry powder | 0.1–1 mM |
Probe | NFK Green™ | Ready to use | 1x |
Reference compound IDO1 | NTRC 0820-0 | 10 mM in 100% DMSO | 10 μM |
Reference compound TDO | NTRC 0672-0 | 10 mM in 100% DMSO | 10 μM |
Advantages of NFK Green™
Detection
NFK Green™ assays can be read out using a fluorescence reader with monochromators or filters that can handle excitation at 400 nm and emission detection at 510 nm. PerkinElmer Envision® multilabel plate readers with 400/25 (excitation; M400w) and 510/20 (emission; M510w) filters and the D425/D490 dual mirror have already been successfully used to measure the signal of NFK Green™ assays in 384- and 1536-well format.